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This paper is concerned with the depression of growth of specific tissues of 
the  rat  by steroids  related  to progesterone.  As growth  antagonists,  certain 
members of the pregnane series were found to have the following unique prop- 
erties: The depression of growth  is  selective.  Without  interfering  with  body 
growth,  certain  pregnanes  cause a  decrease in  the size  of the adrenals  and 
ovaries of intact  young rats  compared with  the  size of those of uninjected 
controls. In hypophysectomized rats, these steroids inhibit the growth of the 
uterus  when  administered  concurrently  with  estrone  or  testosterone,  hor- 
mones which are powerful stimulators  of uterine growth. 
Steroidal inhibition  has pertinence in problems of growth, notably cancer. 
It is known that several neoplasms including  those of the prostate of dog (1) 
and man  (2)  are maintained and propagated in their growth by testosterone 
and  that  they undergo  regression  following  the  administration  of phenolic 
estrogens.  These  estrogenic  phenols  while  suppressing  cancers  promote  un- 
desirable  growth  in  the  breast  and  other organs.  The  pregnane  derivatives 
which depress steroid-induced growth have special interest since, administered 
separately,  they excite little  or no cellular  proliferation. 
It will be shown that a fluorine  atom in steroids related to progesterone can 
augment  significantly  their  power  to  inhibit  steroid-induced  growth  and  to 
depress as well glands which synthesize growth-promoting  steroids. 
It has been known for some time that certain steroids in the pregnane series can 
inhibit  the growth-stimulatory effects of phenolic estrogens upon the tissues of the 
female genital tract under special conditions. Conversely the characteristic progesta- 
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tional  effect induced in the uterus  of the rabbit by progesterone  can be completely 
inhibited by large doses of estrone (3, 4). 
The  scarlet  edematous  perineum  induced  by  estradiol  in  the  castrate  baboon 
undergoes complete  deturgescence and becomes pale  when  this  estrogen  is supple- 
mented  with progesterone  (5). Hertz e3 al.  (6) found that the simultaneous  adminis- 
tration of progesterone and phenolic estrogens resulted in a marked inhibition  of the 
estrogen-induced growth of the oviduct of the chick. After a high degree of inhibi- 
tion was obtained, additional  increments of progesterone did not cause further decre- 
ments of estrogen-induced tissue growth.  Also it was observed  (6) that a sixteenfold 
increase  in  estrogen  dosage  did  not reverse  the  inhibitory  action  of a  maximally 
effective quantity of progesterone upon the oviduct. 
The  studies  of  the  school  of  Lipschiitz  on  the  inhibition  of  estradiol-induced 
growth  in the castrate female guinea pig have revealed  that other pregnane  deriva- 
tives  are  also effective inhibitors.  The most powerful inhibitor  of estrogen-induced 
uterine growth described by these workers is 19-norprogesterone (7); other inhibitors 
in  decreasing  order  of  effectiveness are  progesterone  (8,  9),  desoxycorticosterone 
(10),  and  testosterone  (9);  weak  inhibitors  which  they reported  were 11-ketopro- 
gesterone  (ll)  and  ll~-hydroxyprogesterone  (11). Cortisone  (12) was found  not to 
be an inhibitor  of uterine  growth. 
Progesterone  (13) and  desoxycorticosterone  (10) are  such  potent  inhibitors  of 
estradiol in the guinea pig that supplementary  administration  of either of them stops 
uterine  bleeding and permits  closure of the vaginal membrane in the presence of the 
estrogen. 
1  la-Hydroxyprogesterone is the only compound which has been reported  to have 
the capacity to inhibit  growth  induced by steroids in both the estrane  and andros- 
tane series. Bymes, Stafford,  and Olson (14) stated  that  lla-hydroxyprogesterone, 
when administered  to gonadectomized rats in large doses (5  to  I0 rag. daily),  par- 
tially  suppressed uterine  growth  in females treated  with estradiol  and depressed as 
well the growth  of the  seminal vesicles in  males  injected  with  testosterone.  Large 
amounts of this compound produced  a  slight decrease in weight of the ovaries and 
the adrenals in intact rats. 
Recently it was shown by Fried  and Sabo (15, 16) that the introduction of a chlo- 
rine, or especially of a fluorine, atom at position 9 in cortisone, hydrocortisone,  and 
llfl-hydroxyprogesterone  (17) profoundly  increases the capacity of these steroids to 
deposit  glycogen in  the liver  as  well as  to cause retention  of sodium in the body. 
The ability  of these fluorinated  steroids to inhibit  steroid-induced growth of tissues 
has not been described. 
The present  studies  consisted in  the administration  of derivatives  of ster- 
oids in  the pregnane series  alone or in addition to estrone or testosterone to 
hypophysectomized rats  maintained  under  highly  standardized  conditions. 
Compounds which  were  found to be  the most effective steroid  inhibitors  in 
hypophysectomized animals were then administered to intact young rats. The 
principal indicator of suppressive effect was growth of the uterus, and this is 
defined as an increase of weight and of nitrogen content of this organ. Histo- CHARLES HUGGINS AND  ELWOOD V.  ~ENSEN  349 
logical studies  of  the vagina  provided useful  supplementary  evidence of the 
activity of steroids in combination upon  the female genital tract. 
Methods 
The experimental procedure has been described  (18, 19) in detail. In brief, steroids were 
administered on a strict schedule first to hypophysectomized rats kept in a  controlled cli- 
mate and fed a  steroid-free synthetic ration. The steroids were dissolved or suspended  in 
ethyl alcohol and these preparations were diluted with 9 volumes of sesame oil; such freshly 
prepared solutions (0.2 ml. daily) were  injected from age 38 to 44 days inclusive.  When 
combinations of steroids were administered they were dissolved in the same solution.  Tests 
of inhibition of growth were carried out against constant daffy doses of growth-promoting 
steroids; the standard dose of estrone was 0.5 #g., of testosterone, 1 rag.  Througkoul this 
paper dosage refers to the amount administered each day. 
Six rats were tested at each dose level of every compound.  Each compound  was tested 
in triplicate at least and on fresh batches of rats and at different times. In studies of inhi- 
bition the statistical probability, P, of a significant  effect was derived from Fisher's table 
(20) of t values. The results were considered significant  when P  values less than 0.02 were 
obtained for both nitrogen content  and  uterine weight. 
Necropsy was performed at age 45  days. The uterus was excised, blotted lightly, and 
weighed.  Its nitrogen content was determined by a  micro-Kjeldahl technique;  the results 
are stated as percentage of nitrogen (gin./100 gra.) of the moist weight of the uterus. Par- 
afire sections of the vagina were stained with hematoxylin and eosin, and with celestin blue 
for mucoprotein. 
Intact female rats were injected with steroids daily from age 23 to 50 days with necropsy 
at age 51 days. The preputial glands, thymus, adrenals, and ovaries were weighed in addi- 
tion to the uterus and vagina. 
Chem/ca/.--Many of  the  steroids were  obtained  from  other  laboratories.  1 4-Pregnen- 
20~-oi-3-one, 4-pregnen-20-one,  and 4-androsten-3-one  were  synthesized  in this laboratory 
by methods to be described elsewhere. 
RESULTS 
Characteristics  of  Uterine  Growth  Induced  by  Estrone  or  Testosterone.--In- 
creasing amounts of estrone or testosterone promote brisk growth of the vagina 
and uterus of the hypophysectomized rat until a  plateau of growth is reached; 
estrone, 0.5/2g.  (19)  or testosterone, 1 nag.  (21), the standard doses employed 
in  these  experiments,  are amounts  considerably larger than  are required for 
the weight  of  the uterus to reach the  growth  plateau.  The  type  of  growth 
which  these  steroids  evoke differs considerably. 
The  uterus  of  uninjected  hypophysectomized rats  is  delicate,  thread-like 
and opaque; the average concentration of nitrogen in 34 uteri was 2.9 ±  0.1 
per  cent.  The  vagina  is  atrophic. 
The uterus whose growth has been excited by estrone is tough, pale, trans- 
lucent and is distended with fluid; the nitrogen concentration in 16 uteri was 
1 We acknowledge with gratitude generous gifts of compounds  used in these experiments 
from Dr. Josef Fried, the Squibb Institute for Medical Research; Dr. D. H. Peterson, The 
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2.52  4- 0.1 per cent. The vagina of rats with such uteri is opaque and many 
long keratin  fibres  are  visible  by microscopy; mucoprotein is  not present. 
The uterus  whose growth has  been provoked by testosterone  is soft, jelly- 
like,  red in color due to dilated capillaries and contains little or no secretion; 
the nitrogen concentration in 16  uteri  was 2.09  :t:  0.05  per cent.  The vagina 
is pale,  translucent  and contains much mucoprotein. 
The administration  of estrone 0.5 gg. and  testosterone  1 rag. together did 
not result in decrease in size of the uterus.  Some of the physiologic character- 
TABLE I 
Inhibitors of Estrone-Induzed Growtk of Uterus 
In all cases estrone 0.S #g. injected daily with or without added steroids. A indicates the 
change in uterine weight induced by added steroids. The rats were hypophysectomized. 
No. 
I 
II 
Ill 
IV 
V 
VII 
VIII 
IX 
X 
Added steroid 
(a) Strong iahibi~ors 
Progesterone 
5-Pregnene-3,20-dione 
Desoxycorticosterone 
9a-Fluoro- l l~-hydroxypro- 
gesterone 
9a-Fluorohydrocortisone 
(b) Weak inMMtors 
4-Pregnen-20/~-ol-3-one 
5-Pregnen-3/~-ol-20-one 
1  l~-Hydroxyprogesterone 
Cortisone 
Hydrocortisone 
Daily 
dose 
~g. 
250 
1000 
250 
250 
250 
1000 
I000 
1000 
1000 
I000 
Change in 
body weight 
gm. 
+1 
+2 
+1 
--I 
--3 
+1 
+5 
--2 
--8 
--8 
Weight of uterus 
Estrone  Estrone + 
alone  added steroid 
mg.  mg. 
126 -4- 12  80 4- 9 
128 q- 15  81 4- 10 
131 4- 13  84 -4- 11 
126 4- 12  62 4- 10 
120 4- 12  59 4- 12 
128 4- 21  92 4- 14 
128 4- 15  98 4- 11 
137 4- 21  107 q- 23 
128 4- 21  108 4- 17 
128 4- 21  109 4- 12 
per  ¢¢tt~ 
--36 
--37 
--36 
--51 
-51 
-28 
-23 
-22 
-16 
I 
-IS 
-4- indicates standard deviation. 
istics  of each compound are present.  The uterus  is pink,  soft,  and distended 
with  secretion.  The  nitrogen  concentration  was  2.31  -4-  0.I  per  cent.  The 
vagina is pale, soft, and gelatinous; keratin fibres are absent and an outstand- 
ing characteristic is the large amount of mucoprotein which is present. 
Pregnane  Inhibitors  of Estrone-Induced  Uterine  Grow/h.--Members  of  the 
pregnane  series  which  inhibited  the growth of the  uterus  when administered 
with  estrone  were  classified  as strong or weak  inhibitors  (Table  I). 
Our  criteria  for  strong  inhibitors  are  fourfold:  (a)  All  values  of  uterine 
growth  (weight and  nitrogen  content)  must  be lower  than  the  lowest  deter- 
ruination  found in  the absence of the inhibitor.  (b)  The weight and nitrogen 
content  of the  uterus  in  the  presence  of estrone  and  the  inhibitor  must  be CHARLES  HUGGLN'S AND  ELW00D  V.  yF_,NSEN  351 
diminished more than 30 per  cent of average values obtained when estrone 
alone was administered. (c) The P  value of Fisher (20) must be less than 0.01. 
(d)  Repeated assays at different times must yield inhibition of a  consistent 
order of magnitude. 
In the case of weak inhibitors, the order of inhibition was 15 to 28 per cent 
of the growth obtained when estrone alone was injected. The P  values were 
less than 0.02.  The results were in agreement in serial experiments at various 
times. 
The  nitrogen  concentration of all the  uteri  of rats  treated  with  estrone 
with or without added pregnane compounds, fell in a  closely grouped series, 
the range being 2.47 to 2.6 per cent, so that a  simple determination of incre- 
ment of uterine weight was a  significant criterion of growth. 
Progesterone  (I)  ~ is  a  strong  inhibitor  of  estrone-induced  growth  of  the 
uterus. A considerable inhibition was obtained when 0.1 rag. of progesterone 
was administered and an increase of dose of this compound to 3 rag. did not 
enhance the effect (Text-fig. 2). 9a-Fluoro-ll/3-hydroxyprogesterone (IV) and 
9a-fluorohydrocortisone (V)  were more effective inhibitors than progesterone 
(Table I). 
A  significant loss of body weight (Table I)  resulted when 9~-fluorohydro- 
cortisone, cortisone (IX), or hydrocortisone (X) was injected at dosage levels 
required to exert inhibitory effects against estrone. The loss of weight with 
9a-fluoro-ll/~-hydroxyprogesterone (FHP)  3 in dosage up  to 0.5  rag.  was in- 
constant or slight. 
None of the pregnane inhibitors, in the absence of estrone, induced growth 
of the vagina or uterus in dosage up to 1 rag. The preputial glands of hypo- 
physectomized rats weighed 8 to 9 mg. FHP, 0.25  to 1 rag. daily caused an 
increment of weight of these structures to  10 to  13 rag. 
Many members of the pregnane series (Table II)  failed to modify signifi- 
cantly the effectiveness of estrone in promoting growth. 
Effect  of Pregnane-Inhibitors  of Estrone on the  Vaginal  Epithelium.--When 
injected with estrone, only 2 steroids in the pregnane series caused transfor- 
mation of  the  vaginal epithelium to mucus  cells.  The  effective compounds 
were progesterone and FHP. 
Progesterone, 0.25  rag., permitted keratin sheets, characteristic of estrone 
activity, to form in the vagina (Fig.  1)  although this amount was sufficient 
to cause maximal inhibition of uterine growth. When the dosage of proges- 
terone was increased to 0.5 lug. the cells desquamated before keratinizing and 
leucocytes appeared  amidst them (Fig. 2).  Progesterone,  1 mg., caused mu- 
cification  and  many  leucocytes  appeared  amidst  the  vaginal  epithelium 
2 The chemical formulae of the compounds used in these experiments are given in Text 
fig.  1. 
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Tsx'r-FIO. 1.  Chemical formulae of the compounds. 
(Fig. 3); the formation of mucus cells was much less than in pregnancy in the 
rat. 
FlIP  was a  more powerful inhibitor  than  progesterone  of estrone-induced 
growth  of the  vagina.  Mucoprotein  appeared in  the  vaginal epithelium at a CHARLES HUGGINS AND ELWOOD V. JENSEN  353 
M~3_ 
15C 
I0¢ 
50 
I  '  I 
|  o 
+ 
I 
C=O 
~.N3 
C=O 
I  ,  I  I  PROGESTERONE  I 
0  0125  0'.5  1.0  2.0  MG./  DAV  5.0 
TZxT-Fm. 2.  The upper curve shows decrease of weight of the uterus induced by sup- 
plementing  estrone  (0.5/~g.  daily)  with  increasing  amounts  of  progesterone  (abscissae). 
The ordinates indicate weight of the uterus in mi11igrsms. The lower curve is weight of the 
uterus  in  the presence  of progesterone  alone. 
TABLE II 
Non-Inh~itors of Estrone-Induced Growth of Ut~ru~ 
In all cases estrone 0.5/~g. injected daily with or without added steroids. A indicates the 
change in uterine weight induced by added steroids. The rats were hypophysectomized. 
No. 
XI 
XII 
XIH 
XIV 
XV 
XVI 
XVII 
XVIII 
Added steroid 
4-Pregneu-20-one 
4-Androsten-3-one 
6~-Hydroxyprogesterone 
1  la-Hydroxyprogesterone 
16a-Hydroxyprogesterone 
17a-Hydroxyprogesterone 
9a-Fluoro-21-desoxyhydrocortisone 
9a-Fluoro-ll/3-hydroxy-4-sndrostene- 
3,17-dione 
Daily 
dose 
mg. 
1.0 
1.0 
0.5 
1.0 
1.0 
1.0 
0.25 
0.5 
Weight of uterus 
Estrone  Estrone Jr 
alone  added steroid 
mg.  mg. 
109 4- 14  119 4- 15 
119 4- 16  108 4- 14 
119 4- 14  122 4- 18 
109 4- 14  105 4- 11 
109 4- 14  115 4- 11 
109 4- 14  124 ±  24 
128 4- 15  123 4- 17 
ll9 4- 16  105 +  4 
+9 
-9 
+2 
-4 
+6 
+14 
-4 
-12 
lower  dose  level  (Fig.  4)  than  when  progesterone  was  injected,  it  was  more 
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(Fig. 6). 5-Pregnene-3,20-dione (II),  1 mg., injected with estrone caused  dis- 
appearance of keratin and many leucocytes were present in  the vaginal wall 
and fluid but mucoprotein was not present. 
In  large  dosage,  desoxycorticosterone  (III),  9a-fluorohydrocortisone,  and 
llfl-hydroxyprogesterone  (VIII)  caused a  decrease in  the amount of keratin 
fibres but there was pronounced growth of the basal cells of the vagina which 
is characteristic  of estrogenic stimulation,  and mucificafion did not  occur. 
Pregnane Inhibitors of Uterine Growth Induced by Testosterone.--11/3-Hydroxy- 
progesterone and FH_P were strong inhibitors of uterine growth elicited by tes- 
tosterone,  1  rag.  (Table  III).  This  inhibitory  property  was  not  shared  by 
progesterone.  None of these  compounds caused  loss of weight.  FHP was an 
TABLE HI 
Effect of Pregnanes on Te~tosterone-lnduced  Growth of Uterus 
In all cases, testosterone, 1 rag, injected daffy with or without added steroids. A indicates 
the change in uterine weight induced by the added steroids. The rats were hypophysec- 
tomized. 
Added steroid 
Progesterone 
1  l~-Hydroxyprogesterone 
11~-Hydroxyprogesterone 
9o~-Fluoro-1  I/3-hydroxypro- 
gesterone 
9cz-Fluoro-11/~-hydroxypro- 
gesterone 
9cz-Fluorohydrocortisone 
Daily 
dose 
~g. 
1000 
5O0 
10O0 
100 
250 
250 
C~o~e 
inbo  y 
weight 
gm  • 
+2 
+2 
0 
+t 
-I 
-5 
Weight of uterus 
Testosterone  Testosterone  + 
alone  added steroid 
mg.  mg. 
105 -4- 9  100.4-  13 
96 -4- 6  89 4- 6 
104 4- 6  71 4- 14 
1044-6  684-13 
104 4- 6  65 4- 10 
104 4- 6  67 4- 8 
per cerd 
--5 
--7 
--32 
--35 
-38 
-36 
effective inhibitor at a  dosage level of 0.1  rag. The first inhibition of growth 
of  the  uterus  by  llfl-hydroxyprogesterone  was  induced  at  a  dosage  level 
above 0.5 rag. (Table III). 
9~-Fluorohydrocortisone  was  a  strong  inhibitor  of  testosterone-induced 
uterine  growth  but  it  induced  a  significant loss of body weight  (Table III). 
The concentration of nitrogen in the uterus of animals  treated  with  testos- 
terone,  with  or without  supplementary  pregnane  compounds,  was  2.03  to 
2.14  per cent.  In each case keratin sheets  were  absent  and  there  were  con- 
siderable amounts of mucoprotein present, although far less than in pregnancy. 
Pregnane Compounds Administered  to Intact Young Rats.--Progesterone and 
steroids with a  closely related molecular structure were administered to intact 
female rats, beginning at the onset of puberty; the compounds differed in the 
number of hydroxyl groups  (0 to 3)  and fluorine atoms (0 or  1)  which  were 
present (Table IV). CHARLES  HUGGINS  AND  ELWOOD  V.  JENSEN  355 
~FHP was found to have unusual inhibitory properties. It did not cause loss 
of  body  weight  at  a  dose  level  (0.1  rag.)  such  that  selective  inhibition 
of growth  was  evident.  Whereas  all  the  pregnane  compounds induced  some 
depression of uterine weight relative to that of uninjected controls, only FHP 
was a  strong inhibitor of growth of the uterus.  FHP  caused  a  significant de- 
TABLE IV 
Pregnane Derivatives Administered to Intar,~ Rats 
Compounds were injected  daily from age 23 to 50 days with autopsy at age 51 days. 
There were 8 female rots in each group. The weight at age 23 days was 43 to 46 gin. 
Compound 
None; unlnjected 
Progesterone 
OH, O; F, 0 
1  lfl-Hydroxyprogest erone 
OH, 1; F, 0 
9a-Fluoro-  1  lfl-hydroxypro- 
gseterone 
OH, I; F, 1 
9a-Fluoro-1 lfl-hydroxypro- 
gesterone 
OH, 1; F, 1 
9a-Fluoro-21-desoxyhydro- 
cortisone 
OH, 2; F, 1 
9ce-Fluorohydrocor  tisone 
OH, 3; F, i 
Daily Final I 
dose  webeb~t  [ 
mg.  gm. 
--  11681 
1).2  ~ 169 
0.2  166 I 
0.1  176 
0.2  159 
0.1  156 
0.1  139 
mg. 
503 
.523 
471 
444 
327 
387 
186 
atial  Adrenals  Ovaries 
ands 
rag.  [  rag.*  rag,* 
88  56  50 
(48-64)  (44-56) 
[17  53  51 
(45-64)  (44-70) 
96  54  50 
(43-68)  (45-6O) 
88  39  43 
(28-47)  (34-S5) ' 
74  33  31  ] 
(23-45)1 (23-34)! 
90  41  48  [ 
(32--46) (36-59)i 
96  33  57 
(18--40) I  (52-70) 
Uterus 
rag.* 
341 
(298-409) 
25O 
(180--329) 
268 
(232-327) 
192 
(118-330) 
A 
Uterus 
per cent 
-27 
-21 
-44 
167  I --51 
(i11-275) 
259  I --24 
(164-314) 
278  -  18 
(188-416) 
* Average values and the range of weight. A, the change in weight of uterus with respect 
to uninjected  controls. 
crease  (30 to 41 per cent)  of the weight of the adrenals,  but inhibition of this 
order of magnitude was induced by all of the fluorinated steroids.  FHP alone 
caused a  decrease  (38 per cent)  in the weight of the ovaries. 
The nitrogen concentration of the uteri of the intact rats injected with FHP 
was 2.49 to 3.10 per cent. The vaginal epithelium of 8 rats injected with FlIP 
0.2 mg.  was classified as follows: keratin  sheets,  2; atrophy,  2; mucification, 
4  rats.  The mucification was of extremely high gradc  of an extent only seen 
previously by the authors  in pregnancy.  Mucification of so high a  grade oc- 356  STEROID INHIBITORS  OF GROWTH 
curred with no other compound in this series. The vaginal mucosa of 8 unln- 
jected control rats fell in the following categories: keratin sheets, 5; stratified 
epithelium, 1; mucification (slight),  2. 
DISCUSSION 
Although none of the members of the pregnane series completely suppressed 
growth of the uterus in hypophysectomized rats injected simultaneously with 
large amounts of estrone or testosterone, some of the compounds were found 
to be effective to a  significant  extent. 
Progesterone is a  strong inhibitor of estrone-induced growth of the uterus. 
This compound loses its effectiveness by removal of the ketone group at Ca as 
in 4-pregnen-20-one  (XI)  or the 2-carbon side chain as in 4-androsten-3-one 
(Xn). 
No great modification of the inhibitory characteristics of progesterone fol- 
lowed the reduction of the ketone group in the side chain at C2o to  form 4- 
pregnen-20~-ol-3-one  (V-I) or the introduction of a hydroxyl at position 21 as 
in desoxycorticosterone. Each  change abolished the power of induce vaginal 
mucification.  Progesterone  lost  its  inhibitory  characteristics  when  hydroxy- 
lated at position 6 (/3) (XIII),  16 (~)  (XV) or 17 (a)  (XVI). 
The  efficacy  of progesterone  in  the  inhibition  of estrone-induced  growth 
was weakened by the introduction  of a  hydroxyl group at Cn to form  llfl- 
hydroxyprogesterone; however, this compound was found to be a  significant 
inhibitor of testosterone-induced growth of the uterus when large doses were 
administered.  At  the dosage level  (1  rag.)  employed in  the present  experi- 
ments,  lla-hydroxyprogesterone  (XIV)  did  not  inhibit  steroid-induced 
growth although  in the experiments of Byrues et al.  (14)  this compound ex- 
erted weak inhibitory effects when given in large doses (5 to  10 nag). 
The introduction of a fluorine atom in the 9 (a) position can exert a striking 
influence  on  the  growth-inhibitory  properties  of a  steroid.  Both  FHP  and 
9a-fluorohydrocortisone  are  stronger  inhibitors  of  estrone-induced  growth 
than ll/3-hydroxyprogesterone or hydrocortisone. 
The fluorine atom alone does not bring about the growth-inhibitory activity 
since  9a-fluoro-21-desoxyhydrocortisone (XVII)  and  9a-fluoro-ll/~-hydroxy- 
4-androstene-3,17-dione  (XVIII)  did  not  inhibit  estrone-induced  uterine 
growth. 
Three  compounds,  cortisone,  hydrocortisone,  and  9a-fluorohydrocortisone 
(to a smaller extent) induced a significant  loss of body weight at a  dosage of 
0.25 rag. and inhibition of growth of the uterus following treatment with these 
compounds can be explained at least in part on the basis of a general inhibi- 
tion of protein synthesis. FHP in similar  amount caused slight or no decrease 
in weight of the body. It is known that hydroxyl groups at positions 11,  17, 
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Determination of the concentration of nitrogen in the uterus was helpful in 
the interpretation of the inhibitory effects of FHP. Estrone and testosterone 
induce uterine growth  with  differing and  characteristic values  4 for nitrogen 
concentration. With estrone the nitrogen concentration (about 2.5  per cent) 
of  the  uterus  is  considerably  higher  than  in  testosterone-induced  growth 
(about 2.1 per cent). Although testosterone does not inhibit the growth of the 
uterus when  it  is  administered  with estrone, it modifies the composition of 
the uterus  (nitrogen concentration about 2.3  per cent).  FHP does not alter 
the nitrogen concentration of the uterus; as an inhibitor of estrone, the nitrogen 
concentration  of  the  uterus  remains  characteristic  for  estrone-stimulated 
growth and as an inhibitor of testosterone, the nitrogen content remains low. 
The fluorine atom  in  FHP  intensifies  the  inhibitory characteristics  of  llE- 
hydroxyprogesterone v/s d  ds testosterone or estrone but it does not change 
qualitatively  the  characteristic  uterine  growth  elicited  by  either  of  these 
growth-promoting  steroids. 
Vaginal mucification is not  a  prerequisite to  the  inhibition of growth  by 
steroids.  In common with  testosterone (22), progesterone (23)  and  FHP in- 
duce the formation of mucus cells when administered with  estrone. In con- 
trast  to  testosterone,  these  pregnane  derivatives  are  inhibitors  of  estrone- 
induced growth of the uterus. 1  l~-Hydroxyprogesterone did not cause vaginal 
mucification in rats treated with estrone while FHP was more effective than 
progesterone in this regard. The high grade of mucification of the vagina of 
many of the intact rats to which FHP was administered is similar to that of 
advanced pregnancy; it is evidence that FHP has some of the characteristics 
of a highly active progestational compound. 
In addition to its highly developed progestational activity, there is evidence 
that FHP has some of the physiological properties of an adrenal cortical ster- 
oid. Adrenal atrophy was induced by FI-IP, 9cz-fluoro-21-desoxyhydrocortisone 
and 9c~-fluorohydrocortisone; of these fluorinated steroids only FHP induced 
a decrease of ovarian weight. 
CONCLUSIONS 
Progesterone, 5-pregnene-3,20-dione, and desoxycorticosterone were found 
to be partial but significant inhibitors of estrone-induced growth of the uterus 
4Among  members  of  the  androstane series which are  androgenic  in  that  they 
elicit growth of the prostate and preputial glands of the rat, the site of unsaturation in the 
steroid molecule can determine the ability of the compound to elicit keratin fibres (an es- 
trogenic action) or mucification in the vaginal epithelium (16). As in the case of estrone 
and testosterone these compounds cause chaxacteristic changes in the nitrogen concentra- 
tion of the uterus. 5-Androstene-3~,  17~-diol, 1 rag., induces the formation of keratin fibres 
and  the  average concentration of nitrogen was  2.54 per  cent. 4-Androstene-3~-lTfl-diol, 
1 rag., causes vaginal mucification  and the concentration of nitrogen in the uterus was 2.15 
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of hypophysectomized  rats  but  they did  not  depress  the amount  of growth 
elicited by testosterone. 
The presence  of both  the  2-carbon  side chain  at position  17 and  an  oxy- 
genated function at position 3 is necessary for the inhibitory activity of pro- 
gesterone. The introduction  of a hydroxyl group in the progesterone molecule 
at positions  6  (fl),  11  (a),  16  (a)  or  17  (o0  destroyed its  growth-inhibitory 
activity. 
l lfl-Hydroxyprogesterone is weaker than  progesterone in  the inhibition  of 
estrone-induced  uterine  growth;  unlike  progesterone  it  has  the  capacity  to 
depress growth elicited by testosterone 
The introduction of a fluorine atom in the 9 (¢x) position resulted in a strik- 
ing increase of the growth-inhibitory activity of 11fl-hydroxyprogesterone and 
hydrocortisone. 
9a-Fluoro-llfl-hydroxyprogesterone  is a  partial  but significant  inhibitor  of 
growth of the uterus in hypophysectomized rats injected simultaneously with 
large doses of estrone or testosterone.  It is more powerful than  progesterone 
in  transforming  the  vaginal  epithelium  to  mucus  cells  in  the  presence  of 
estrone. Administered  alone, the only detectable growth was a  slight increase 
in size of the preputial glands. 
9o~-Fluoro-llfl-hydroxyprogesterone  suppresses  in  part  the  growth  of  the 
adrenals, ovaries, and uterus in intact rats at a dose level which does not cause 
loss of body weight or inhibit body growth. Many rats treated with this com- 
pound  in  small amount  had  extensive mucification  of the vagina  resembling 
that of late pregnancy. 
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EXPLANATION OF PLATE 40 
The photomicrographs are of paraffin sections of the vaginal mucosa stained with 
hematoxylin and eosin. The magnification of each is  X  350. 
In each case a standard amount of estrone, 0.5 #g. daily, had been injected with 
various steroids  in  the daily dosage stated  below each photomicrograph, from age 
38 to 44 days with necropsy at 45 days. 
The  photomicrographs  show  that  9aofluor-ll~-hydroxyprogesterone  (adminis- 
tered  with  estrone)  induces more mucification of the vaginal  epithelium  and  at  a 
lower dosage than progesterone does. 
FIG. 1. Long keratin sheets are present; this is characteristic of unmodified estrone 
activity. 
FIG. 2. The keratin sheets are short and leucocytes are present in the vaginal se- 
cretion. 
FIG. 3. Many mucous cells are seen in the vaginal epithelium and leucocytes are 
visible between these cells and in the vaginal secretion. 
FIG. 4. Mucous cells  are seen on the surface of the vaginal mucosa. 
FzG. 5. The mucous cells  are more extensive than in Figs.  3 and 4. 
FIG. 6. While  mucification  of the vaginal  epithelium  was  extensive  when  9a- 
fluoro-11fl-hydroxyprogesterone  was administered  at a dosage level  of i mg., leuco- 
cytes were not present. The vaginal epithelium  is thinner at this dosage level than 
occurred when 0.5 rag.  was the daily amount of the inhibitor. THE JOURNAL OF EXPERIMENTAL  MEDICINE VOL. 102  PLATE 40 
(Huggins and Jensen: Steroid inhibitors of growth) 